September 12, 2024
View Full PaperSupplementary Protocol S1 from A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170)
Key Points
Key points are not available for this paper at this time.
Abstract
Supplementary Protocol S1 shows the entire clinical trial protocol to supplement the Materials and Methods section.